JP2005514422A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514422A5
JP2005514422A5 JP2003558012A JP2003558012A JP2005514422A5 JP 2005514422 A5 JP2005514422 A5 JP 2005514422A5 JP 2003558012 A JP2003558012 A JP 2003558012A JP 2003558012 A JP2003558012 A JP 2003558012A JP 2005514422 A5 JP2005514422 A5 JP 2005514422A5
Authority
JP
Japan
Prior art keywords
group
azabicyclo
groups
oct
ene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003558012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514422A (ja
JP4402957B2 (ja
JP2005514422A6 (ja
Filing date
Publication date
Priority claimed from FR0200109A external-priority patent/FR2834511B1/fr
Application filed filed Critical
Publication of JP2005514422A publication Critical patent/JP2005514422A/ja
Publication of JP2005514422A6 publication Critical patent/JP2005514422A6/ja
Publication of JP2005514422A5 publication Critical patent/JP2005514422A5/ja
Application granted granted Critical
Publication of JP4402957B2 publication Critical patent/JP4402957B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003558012A 2002-01-07 2003-01-03 5−(ピリジン−3−イル)−1−アザビシクロ[3.2.1]オクタン誘導体類、それらの製造と治療におけるそれらの適用 Expired - Fee Related JP4402957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR02/00109 2002-01-07
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
JP2005514422A JP2005514422A (ja) 2005-05-19
JP2005514422A6 JP2005514422A6 (ja) 2005-08-04
JP2005514422A5 true JP2005514422A5 (enExample) 2007-07-26
JP4402957B2 JP4402957B2 (ja) 2010-01-20

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003558012A Expired - Fee Related JP4402957B2 (ja) 2002-01-07 2003-01-03 5−(ピリジン−3−イル)−1−アザビシクロ[3.2.1]オクタン誘導体類、それらの製造と治療におけるそれらの適用

Country Status (35)

Country Link
US (2) US7223750B2 (enExample)
EP (1) EP1465893B1 (enExample)
JP (1) JP4402957B2 (enExample)
KR (1) KR100977332B1 (enExample)
CN (2) CN1911928A (enExample)
AR (2) AR038098A1 (enExample)
AT (1) ATE355290T1 (enExample)
AU (1) AU2003216777B2 (enExample)
BR (1) BR0306707A (enExample)
CA (1) CA2471628C (enExample)
CO (1) CO5590914A2 (enExample)
CY (1) CY1106580T1 (enExample)
DE (1) DE60312123T2 (enExample)
DK (1) DK1465893T3 (enExample)
EA (1) EA007793B1 (enExample)
EC (1) ECSP045176A (enExample)
ES (1) ES2281631T3 (enExample)
FR (1) FR2834511B1 (enExample)
HR (1) HRP20040617B1 (enExample)
IL (2) IL162524A0 (enExample)
IS (1) IS2470B (enExample)
MA (1) MA27165A1 (enExample)
ME (2) MEP24408A (enExample)
MX (1) MXPA04006630A (enExample)
NO (1) NO329309B1 (enExample)
NZ (1) NZ533793A (enExample)
PL (1) PL216665B1 (enExample)
PT (1) PT1465893E (enExample)
RS (1) RS50921B (enExample)
SI (1) SI1465893T1 (enExample)
TN (1) TNSN04120A1 (enExample)
TW (1) TWI336703B (enExample)
UA (1) UA77229C2 (enExample)
WO (1) WO2003057697A1 (enExample)
ZA (1) ZA200405002B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) * 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101925971B1 (ko) 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101928505B1 (ko) 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR20200083976A (ko) 2017-11-03 2020-07-09 알콘 인코포레이티드 눈 장애의 치료를 위한 아자바이시클로 및 디아제핀 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
AU7474794A (en) 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
JP4896518B2 (ja) ニコチンアミド系キナーゼ阻害薬
ES2549087T3 (es) Derivados de aminodihidrotiazina como inhibidores de BACE para el tratamiento de la enfermedad de Alzheimer
CN104379578B (zh) 氨基甲酸酯化合物及其制备和使用方法
JP2006524222A5 (enExample)
JP2006514656A (ja) Cb1/cb2受容体リガンドおよび疼痛の治療におけるその使用
EA027780B1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
JP2005516969A (ja) メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
AR041302A1 (es) Compuestos de imidazopiridina como agonistas del receptor 5- ht4 y composiciones farmaceuticas que comprenden dichos compuestos
WO2002016355A3 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
TWI387577B (zh) 非對稱性合成
JP2007528883A5 (enExample)
JP2005514422A5 (enExample)
JPWO2020132014A5 (enExample)
JP2008510719A5 (enExample)
KR20130119927A (ko) 이미다졸 유도체, 그의 제조 방법 및 용도
ZA200207381B (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain.
ES2228413T3 (es) Productos intermedios y un procedimiento para producir agonistas de receptores beta-adrenergicos.
JPS6335571A (ja) 抗生物質の中間体
US10202401B2 (en) Process for making tetracyclic heterocycle compounds
JP2015523985A (ja) ジアリールヨードニウム塩を製造するための方法及び反応剤
AR038098A1 (es) Derivados de 5-(piridin-3-il)-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica
WO2016139773A1 (ja) シロドシン合成中間体の新規合成方法
KR900011759A (ko) 사이클로 헥산아세트 아미드 유도체
JP2005255660A (ja) 多官能基を有するラクタム類とその製法
ES2285972T1 (es) Procedimiento de fabricacion de citalopram y enantiomeros.